StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Kazia Therapeutics's total assets was A$71.11M at Dec 31, 2025. For fiscal 2025 it was A$6.06M, down 71.9% from the year before. The highest annual figure on record is A$57.09M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$6.06M-71.9%
FY2024Jun 30, 2024A$21.59M-23.1%
FY2023Jun 30, 2023A$28.08M-21.7%
FY2022Jun 30, 2022A$35.89M-37.1%
FY2021Jun 30, 2021A$57.09M+147.6%
FY2020Jun 30, 2020A$23.06M+8.9%
FY2019Jun 30, 2019A$21.18M-24.8%
FY2018Jun 30, 2018A$28.18M-21.5%
FY2017Jun 30, 2017A$35.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025A$71.11M+191.6%
Q4 FY2025CQ2 2025Jun 30, 2025A$6.06M-78.4%
Q2 FY2025CQ4 2024Dec 31, 2024A$17.91M-35.7%
Q4 FY2024CQ2 2024Jun 30, 2024A$21.59M-39.9%
Q2 FY2024CQ4 2023Dec 31, 2023A$24.38M-57.3%
Q4 FY2023CQ2 2023Jun 30, 2023A$28.08M+21.8%
Q2 FY2023CQ4 2022Dec 31, 2022A$27.84M+31.4%
Q4 FY2022CQ2 2022Jun 30, 2022A$35.89M+27.4%
Q4 FY2021CQ2 2021Jun 30, 2021A$57.09M+59.0%
Q4 FY2020CQ2 2020Jun 30, 2020A$23.06M–
Q4 FY2019CQ2 2019Jun 30, 2019A$21.18M–
Q4 FY2018CQ2 2018Jun 30, 2018A$28.18M–
Q4 FY2017CQ2 2017Jun 30, 2017A$35.91M–

More Kazia Therapeutics figures

See a number that looks wrong?